Brookstone Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.7M Buy
123,288
+3,848
+3% +$427K 0.18% 138
2025
Q1
$13.4M Sell
119,440
-28,012
-19% -$3.14M 0.19% 129
2024
Q4
$13.6M Buy
147,452
+600
+0.4% +$55.4K 0.2% 121
2024
Q3
$12.3M Buy
146,852
+992
+0.7% +$83.2K 0.18% 130
2024
Q2
$10.7M Buy
145,860
+18,602
+15% +$1.36M 0.18% 137
2024
Q1
$9.32M Buy
127,258
+112,305
+751% +$8.23M 0.17% 151
2023
Q4
$1.21M Buy
14,953
+406
+3% +$32.9K 0.02% 418
2023
Q3
$1.14M Buy
14,547
+1,390
+11% +$109K 0.03% 404
2023
Q2
$979K Buy
13,157
+625
+5% +$46.5K 0.02% 439
2023
Q1
$1.05M Sell
12,532
-2,415
-16% -$202K 0.02% 445
2022
Q4
$1.32M Sell
14,947
-154,213
-91% -$13.6M 0.03% 376
2022
Q3
$11.1M Buy
169,160
+9,145
+6% +$598K 0.26% 97
2022
Q2
$10.1M Buy
160,015
+55,379
+53% +$3.48M 0.22% 110
2022
Q1
$6.48M Buy
104,636
+28,881
+38% +$1.79M 0.13% 157
2021
Q4
$5.4M Sell
75,755
-439
-0.6% -$31.3K 0.09% 173
2021
Q3
$5.15M Buy
76,194
+12,760
+20% +$863K 0.09% 174
2021
Q2
$4.31M Buy
63,434
+12,518
+25% +$851K 0.08% 193
2021
Q1
$3.29M Sell
50,916
-959
-2% -$62K 0.13% 145
2020
Q4
$3.02M Buy
51,875
+6,875
+15% +$401K 0.12% 140
2020
Q3
$2.84M Buy
45,000
+13,514
+43% +$854K 0.13% 114
2020
Q2
$2.42M Sell
31,486
-7,651
-20% -$589K 0.15% 99
2020
Q1
$2.93M Buy
+39,137
New +$2.93M 0.17% 81
2019
Q4
Sell
-18,048
Closed -$1.14M 431
2019
Q3
$1.14M Sell
18,048
-16,456
-48% -$1.04M 0.06% 171
2019
Q2
$2.33M Buy
+34,504
New +$2.33M 0.13% 125
2018
Q4
Sell
-63,479
Closed -$4.9M 340
2018
Q3
$4.9M Sell
63,479
-6,727
-10% -$519K 0.37% 68
2018
Q2
$4.97M Sell
70,206
-2,348
-3% -$166K 0.43% 66
2018
Q1
$5.47M Buy
72,554
+1,826
+3% +$138K 0.5% 65
2017
Q4
$5.07M Buy
+70,728
New +$5.07M 0.46% 90
2015
Q4
Sell
-827
Closed -$81K 436
2015
Q3
$81K Sell
827
-494
-37% -$48.4K 0.01% 307
2015
Q2
$155K Buy
+1,321
New +$155K 0.02% 266